EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Clinical Trials

EMD Serono, Inc. is committed to developing new therapies to treat serious illnesses. One of the most important steps in this process are clinical trials, where people volunteer to receive an experimental therapy and be observed for its effects.
Our fully integrated Clinical Development operations range from early-stage to full clinical development management of the organization's clinical trials. In addition, our Medical Organization, focused on advancing scientific and medical knowledge, manages Phase IV and registry studies. This integrated approach enables us to develop innovative products that have a positive impact on patients’ lives, and to ensure that these products continue to meet our high standards for safety and efficacy once they reach the market.
EMD Serono is currently conducting clinical trials within four therapeutic areas—neurodegenerative diseases, oncology, fertility, and endocrinology. To find a listing and enroll in one of EMD Serono’s clinical trials, visit http://clinicaltrials.gov/.
Responsible Data Sharing
EMD Serono has established policies and procedures to implement the PhRMA/EFPIA Responsible Data Sharing Principles. EMD Serono's data request review process and the identity of the external scientists and healthcare professionals who will be participating in EMD Serono's scientific review board are available upon request, and in the near future will be posted on EMD Serono's website.


More questions about Clinical Trials?